T3 Companies’s Select Medical SEM Stock Holding History

T3 Companies’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Buy	+20,000	New	+$330K	0.35%	56
2026 Q1	–	Sell	-20,600	Closed	-$306K	–	236
2025 Q4	$306K	Buy	+20,600	New	+$291K	0.38%	53

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

T3 Companies's SEM Position: Q2 2026 in Review

T3 Companies opened a new position in Select Medical (SEM) in Q2 2026: 20,000 shares worth $330K. The stake represents 0.35% of the portfolio and ranks #56 among its holdings. This is a return to the name: T3 Companies previously reported a position in SEM as recently as Q4 2025.

T3 Companies first reported a position in SEM in Q4 2025 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

T3 Companies held 20,000 shares of Select Medical worth $330K as of Q2 2026.
Select Medical was a new T3 Companies position in Q2 2026.
Select Medical made up 0.35% of T3 Companies's portfolio in Q2 2026, its #56 holding.
T3 Companies first reported a position in Select Medical in Q4 2025 and has held it in 2 quarters since.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.